---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-006468"
form_type: "8-K"
ticker: "CHRN"
cik: "0001549084"
company_name: "EKSO BIONICS HOLDINGS, INC."
filed_at: "2022-01-21T23:59:59+00:00"
generated_at: "2026-06-27T16:29:51.924683+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Ekso Bionics CEO Peurach resigns; Chairman Sherman becomes CEO

## Summary
- CEO Jack Peurach resigns effective Jan 21, 2022; receives severance of 9 months salary, $187,250 lump sum, and RSU acceleration.
- Chairman Steven Sherman appointed CEO effective Jan 22; will receive equity award in lieu of $453K annual cash salary.
- Scott Davis promoted to President and COO from EVP Strategy and Corporate Development.
- Board appoints new committee chairs; Stanley Stern becomes Lead Independent Director.
- Press release notes record Q4 2021 revenue and momentum in inpatient rehab and industrial sales.

## SEC filing metadata
- accession: 0001104659-22-006468
- form_type: 8-K
- ticker: CHRN
- cik: 0001549084
- company_name: EKSO BIONICS HOLDINGS, INC.
- filed_at: 2022-01-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/tm223985d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-006468
- JSON: https://secwatch.observer/filing/0001104659-22-006468.json
- Plain text: https://secwatch.observer/filing/0001104659-22-006468.txt

## Key facts
- Executive change
  Stanley Stern was appointed as Lead Independent Director at EKSO BIONICS HOLDINGS, INC..
  - Action: designated
  - Role: Lead Independent Director
  source text: Board member Stanley Stern has been designated the Board’s lead independent director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm
- Executive change
  Steven Sherman was appointed as Chief Executive Officer at EKSO BIONICS HOLDINGS, INC..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: the Company’s Board appointed Steven Sherman, who currently serves as the Chairman of the Board, to become Chief Executive Officer of the Company effective January 22, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm
- Executive change
  Jack Peurach resigned as President, Chief Executive Officer and a director at EKSO BIONICS HOLDINGS, INC..
  - Action: resigned
  - Role: President, Chief Executive Officer and a director
  source text: Jack Peurach, the President, Chief Executive Officer and a director of Ekso Bionics Holdings, Inc. (the “Company”), notified the Company of his intention to resign as an officer and member of the Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1549084/000110465922006468/0001104659-22-006468-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.